| Robert D Mccroskey, MD | |
|
2920 South Meridian, Suite 100, Puyallup, WA 98373-1428 | |
| (253) 841-4296 | |
| (253) 841-2435 |
| Full Name | Robert D Mccroskey |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 41 Years |
| Location | 2920 South Meridian, Puyallup, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629064589 | NPI | - | NPPES |
| 99334 | Other | WA | L AND I |
| 1067685 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD00028658 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Multicare Good Samaritan Hospital | Puyallup, WA | Hospital |
| St Joseph Medical Center | Tacoma, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Medical Specialties Pllc | 8022903384 | 35 |
News Archive
Globally, pneumonia and diarrhea together led to nearly one of every four deaths that occurred in children under five years of age in 2016.
The annual Australian technology "Academy Awards" presentation marked a significant milestone for Sydney headquartered technology company Iris Interactive taking out three awards which sets them up for the world stage. Iris Interactive started 15 years ago by a working mother, Janaki Joshi, who identified a gap in the market for enterprise software focused on product commercialisation.
When you're facing a cancer diagnosis with an average survival span of 12 to 18 months, every milestone is a victory.
DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced it has entered into an exclusive license agreement with the University of Florida, Gainesville to develop a novel oncolytic virus platform.
› Verified 8 days ago
| Entity Name | Northwest Medical Specialties Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548261308 PECOS PAC ID: 8022903384 Enrollment ID: O20040217000405 |
News Archive
Globally, pneumonia and diarrhea together led to nearly one of every four deaths that occurred in children under five years of age in 2016.
The annual Australian technology "Academy Awards" presentation marked a significant milestone for Sydney headquartered technology company Iris Interactive taking out three awards which sets them up for the world stage. Iris Interactive started 15 years ago by a working mother, Janaki Joshi, who identified a gap in the market for enterprise software focused on product commercialisation.
When you're facing a cancer diagnosis with an average survival span of 12 to 18 months, every milestone is a victory.
DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced it has entered into an exclusive license agreement with the University of Florida, Gainesville to develop a novel oncolytic virus platform.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert D Mccroskey, MD 1624 South I Street, Suite 305, Tacoma, WA 98405-5093 Ph: (253) 428-8700 | Robert D Mccroskey, MD 2920 South Meridian, Suite 100, Puyallup, WA 98373-1428 Ph: (253) 841-4296 |
News Archive
Globally, pneumonia and diarrhea together led to nearly one of every four deaths that occurred in children under five years of age in 2016.
The annual Australian technology "Academy Awards" presentation marked a significant milestone for Sydney headquartered technology company Iris Interactive taking out three awards which sets them up for the world stage. Iris Interactive started 15 years ago by a working mother, Janaki Joshi, who identified a gap in the market for enterprise software focused on product commercialisation.
When you're facing a cancer diagnosis with an average survival span of 12 to 18 months, every milestone is a victory.
DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced it has entered into an exclusive license agreement with the University of Florida, Gainesville to develop a novel oncolytic virus platform.
› Verified 8 days ago
Miao Huang, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 407 14th Ave Se, Puyallup, WA 98372 Phone: 253-697-4000 | |
Lynn C Ostenson, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 407 14th Ave Se, Puyallup, WA 98371 Phone: 253-697-4000 | |
Martin Mao-ting Lee, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 702 23rd Ave Se, Puyallup, WA 98372 Phone: 253-841-4378 | |
John David Piatt, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 12005 Meridian E Ste 101, Puyallup, WA 98373 Phone: 253-215-1095 Fax: 253-215-1096 | |
Seyed Abdol Reza Jalali, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2910 S Meridian Ste 350, Puyallup, WA 98373 Phone: 253-445-5750 Fax: 253-426-4142 | |
Dr. Janet Jayshree Singh, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 401 15th Ave Se, Puyallup, WA 98372 Phone: 253-697-7655 | |
Michael Gregory Blackburn, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 201 15th Ave Sw Ste C, Puyallup, WA 98371 Phone: 253-841-4243 Fax: 253-864-9452 |